The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Management of Salivary Gland Malignancy: ASCO Guideline
Abstract
PURPOSE: To provide evidence-based recommendations for practicing physicians and other healthcare providers on the management of salivary gland malignancy. METHODS: ASCO convened an Expert Panel of medical oncology, surgical oncology, radiation oncology, neuroradiology, pathology, and patient advocacy experts to conduct a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and prospective and retrospective comparative observational studies published from 2000 through 2020. Outcomes of interest included survival, diagnostic accuracy, disease recurrence, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations. RESULTS: The literature search identified 293 relevant studies to inform the evidence base for this guideline. Six main clinical questions were addressed, which included subquestions on preoperative evaluations, surgical diagnostic and therapeutic procedures, appropriate radiotherapy techniques, the role of systemic therapy, and follow-up evaluations. RECOMMENDATIONS: When possible, evidence-based recommendations were developed to address the diagnosis and appropriate preoperative evaluations for patients with a salivary gland malignancy, therapeutic procedures, and appropriate treatment options in various salivary gland histologies. Additional information is available at www.asco.org/head-neck-cancer-guidelines .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Marabelle, A., Fakih, M., Lopez, J., Shah, M., Shapira-Frommer, R., Nakagawa, K., Chung, H. C., Kindler, H. L., Lopez-Martin, J. A., Miller, W. H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30445-9 · Cited by 2,552 · cited 2×
“Although pembrolizumab carries a primary site agnostic US Food and Drug Administration approval for mismatch repair–deficient tumors, it is important to note that this was based on a nine-patient cohort of noncolorectal cancer patients, none of whom had salivary gland malignancies.(43,358) Similarly, pembrolizumab is…”
BackgroundFerrell, B. R., Temel, J. S., Temin, S., Alesi, E. R., Balboni, T. A., Basch, E. M., Firn, J. I., Paice, J. A., Peppercorn, J. M., Phillips, T., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.1474 · Cited by 2,117
Doebele, R. C., Drilon, A., Paz-Ares, L., Siena, S., Shaw, A. T., Farago, A. F., Blakely, C. M., Seto, T., Cho, B. C., Tosi, D., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30691-6 · Cited by 1,790
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
Hyman, D. M., Puzanov, I., Subbiah, V., Faris, J. E., Chau, I., Blay, J.-Y., Wolf, J., Raje, N. S., Diamond, E. L., Hollebecque, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502309 · Cited by 1,764
World Health Organization Classification of Tumours
Jn, E. (2004) · Medical Entomology and Zoology · Cited by 1,501
Salivary neoplasms: Overview of a 35‐year experience with 2,807 patients
Spiro, R. H. (1986) · Head & Neck Surgery · doi:10.1002/hed.2890080309 · Cited by 1,455
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Pfister, D. G., Spencer, S., Adelstein, D., Adkins, D., Anzai, Y., Brizel, D. M., Bruce, J. Y., Busse, P. M., Caudell, J. J., Cmelak, A. J., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0031 · Cited by 1,360
Self-citationPalma, D. A., Olson, R., Harrow, S., Gaede, S., Louie, A. V., Haasbeek, C., Mulroy, L., Lock, M., Rodrigues, G. B., Yaremko, B. P., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00818 · Cited by 1,300
Hong, D. S., DuBois, S. G., Kummar, S., Farago, A. F., Albert, C. M., Rohrberg, K. S., van Tilburg, C. M., Nagasubramanian, R., Berlin, J. D., Federman, N., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30856-3 · Cited by 1,028
Skálová, A., Vanecek, T., Sima, R., Laco, J., Weinreb, I., Perez-Ordonez, B., Starek, I., Geierova, M., Simpson, R. H., Passador-Santos, F., et al. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181d9efcc · Cited by 1,023
Schnipper, L. E., Davidson, N. E., Wollins, D. S., Tyne, C., Blayney, D. W., Blum, D., Dicker, A. P., Ganz, P. A., Hoverman, J. R., Langdon, R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6706 · Cited by 912
Baloch, Z. W., LiVolsi, V. A., Asa, S. L., Rosai, J., Merino, M. J., Randolph, G., Vielh, P., DeMay, R. M., Sidawy, M. K., & Frable, W. J. (2008) · Diagnostic Cytopathology · doi:10.1002/dc.20830 · Cited by 880
Lievens, Y., Guckenberger, M., Gomez, D., Hoyer, M., Iyengar, P., Kindts, I., Méndez Romero, A., Nevens, D., Palma, D., Park, C., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.04.003 · Cited by 672
Schnipper, L. E., Davidson, N. E., Wollins, D. S., Blayney, D. W., Dicker, A. P., Ganz, P. A., Hoverman, J. R., Langdon, R., Lyman, G. H., Meropol, N. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.2518 · Cited by 655
American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
Meropol, N. J., Schrag, D., Smith, T. J., Mulvey, T. M., Langdon, R. M., Blum, D., Ubel, P. A., & Schnipper, L. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1183 · Cited by 638
Patient-clinician communication: American Society of Clinical Oncology consensus guideline
Gilligan, T., Coyle, N., Frankel, R. M., Berry, D. L., Bohlke, K., Epstein, R. M., Finlay, E., Jackson, V. A., Lathan, C. S., Loprinzi, C. L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.2311 · Cited by 610
Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
Dusetzina, S. B., Winn, A. N., Abel, G. A., Huskamp, H. A., & Keating, N. L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.9123 · Cited by 500
Koyfman, S. A., Ismaila, N., Crook, D., D'Cruz, A., Rodriguez, C. P., Sher, D. J., Silbermins, D., Sturgis, E. M., Tsue, T. T., Weiss, J., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01921 · Cited by 395
Self-citationChen, Y.-P., Ismaila, N., Chua, M. L. K., Colevas, A. D., Haddad, R., Huang, S. H., Wee, J. T. S., Whitley, A. C., Yi, J.-L., Yom, S. S., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.03237 · Cited by 390
Self-citationSchmidt, R. L., Hall, B. J., Wilson, A. R., & Layfield, L. J. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpoie0cznat6sq · Cited by 362
Hotte, S. J., Winquist, E. W., Lamont, E., MacKenzie, M., Vokes, E., Chen, E. X., Brown, S., Pond, G. R., Murgo, A., & Siu, L. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.125 · Cited by 278
Identifying patients with NTRK fusion cancer
Solomon, J. P., Benayed, R., Hechtman, J. F., & Ladanyi, M. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz384 · Cited by 270
Takahashi, H., Tada, Y., Saotome, T., Akazawa, K., Ojiri, H., Fushimi, C., Masubuchi, T., Matsuki, T., Tani, K., Osamura, R. Y., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.00545 · Cited by 266
Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study
Haddad, R., Colevas, A. D., Krane, J. F., Cooper, D., Glisson, B., Amrein, P. C., Weeks, L., Costello, R., & Posner, M. (2003) · Oral Oncology · doi:10.1016/s1368-8375(03)00097-6 · Cited by 264
Agulnik, M., Cohen, E. W. E., Cohen, R. B., Chen, E. X., Vokes, E. E., Hotte, S. J., Winquist, E., Laurie, S., Hayes, D. N., Dancey, J. E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8612 · Cited by 263
Ferrarotto, R., Mitani, Y., Diao, L., Guijarro, I., Wang, J., Zweidler-McKay, P., Bell, D., William, W. N., Glisson, B. S., Wick, M. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.5264 · Cited by 253
Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions
Streeter, S. B., Schwartzberg, L., Husain, N., & Johnsrud, M. (2011) · Journal of Oncology Practice · doi:10.1200/jop.2011.000316 · Cited by 248
Tchekmedyian, V., Sherman, E. J., Dunn, L., Tran, C., Baxi, S., Katabi, N., Antonescu, C. R., Ostrovnaya, I., Haque, S. S., Pfister, D. G., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01859 · Cited by 243
Fakhry, C., Lacchetti, C., Rooper, L. M., Jordan, R. C., Rischin, D., Sturgis, E. M., Bell, D., Lingen, M. W., Harichand-Herdt, S., Thibo, J., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.00684 · Cited by 243
(2008) · Cited by 225
Maghami, E., Ismaila, N., Alvarez, A., Chernock, R., Duvvuri, U., Geiger, J., Gross, N., Haughey, B., Paul, D., Rodriguez, C., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00275 · Cited by 221
Self-citationCetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
Locati, L. D., Bossi, P., Perrone, F., Potepan, P., Crippa, F., Mariani, L., Casieri, P., Orsenigo, M., Losa, M., Bergamini, C., et al. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2008.07.010 · Cited by 218
Self-citationGenetic hallmarks of recurrent/metastatic adenoid cystic carcinoma
Ho, A. S., Ochoa, A., Jayakumaran, G., Zehir, A., Valero Mayor, C., Tepe, J., Makarov, V., Dalin, M. G., He, J., Bailey, M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128227 · Cited by 212
Self-citationCohen, R. B., Delord, J.-P., Doi, T., Piha-Paul, S. A., Liu, S. V., Gilbert, J., Algazi, A. P., Damian, S., Hong, R.-L., Le Tourneau, C., et al. (2018) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000429 · Cited by 211
Mitani, Y., Liu, B., Rao, P. H., Borra, V. J., Zafereo, M., Weber, R. S., Kies, M., Lozano, G., Futreal, P. A., Caulin, C., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2867-t · Cited by 201
Trastuzumab for the Treatment of Salivary Duct Carcinoma
Limaye, S. A., Posner, M. R., Krane, J. F., Fonfria, M., Lorch, J. H., Dillon, D. A., Shreenivas, A. V., Tishler, R. B., & Haddad, R. I. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0369 · Cited by 184
Shiffman, R. N., Michel, G., Rosenfeld, R. M., & Davidson, C. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000172 · Cited by 184
Rodriguez, C. P., Wu, Q. (., Voutsinas, J., Fromm, J. R., Jiang, X., Pillarisetty, V. G., Lee, S. M., Santana-Davila, R., Goulart, B., Baik, C. S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2214 · Cited by 180
Self-citationCisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma
Licitra, L., Cavina, R., Grandi, C., Di Palma, S., Guzzo, M., Demicheli, R., & Molinari, R. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010684 · Cited by 178
Self-citationEvolution of an adenocarcinoma in response to selection by targeted kinase inhibitors
Jones, S. J., Laskin, J., Li, Y. Y., Griffith, O. L., An, J., Bilenky, M., Butterfield, Y. S., Cezard, T., Chuah, E., Corbett, R., et al. (2010) · Genome Biology · doi:10.1186/gb-2010-11-8-r82 · Cited by 175
Prognostic Factors in Major Salivary Gland Cancer
Hocwald, E., Korkmaz, H., Yoo, G. H., Adsay, V., Shibuya, T. Y., Abrams, J., & Jacobs, J. R. (2001) · The Laryngoscope · doi:10.1097/00005537-200108000-00021 · Cited by 173
Jhaveri, K. L., Wang, X. V., Makker, V., Luoh, S.-W., Mitchell, E. P., Zwiebel, J. A., Sharon, E., Gray, R. J., Li, S., McShane, L. M., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz291 · Cited by 151
Williams, M. D., Roberts, D. B., Kies, M. S., Mao, L., Weber, R. S., & El‐Naggar, A. K. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0238 · Cited by 146
Kurzrock, R., Bowles, D. W., Kang, H., Meric‐Bernstam, F., Hainsworth, J. D., Spigel, D. R., Bose, R., Burris, H. A., Sweeney, C. J., Beattie, M. S., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.11.018 · Cited by 140
Jacobson, J. J., Epstein, J. B., Eichmiller, F. C., Gibson, T. B., Carls, G. S., Vogtmann, E., Wang, S. S., & Murphy, B. A. (2012) · Head & Neck Oncology · doi:10.1186/1758-3284-4-15 · Cited by 136
Amini, A., Waxweiler, T. V., Brower, J. V., Jones, B. L., McDermott, J. D., Raben, D., Ghosh, D., Bowles, D. W., & Karam, S. D. (2016) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2016.2168 · Cited by 134
Rooper, L. M., Karantanos, T., Ning, Y., Bishop, J. A., Gordon, S. W., & Kang, H. (2018) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001065 · Cited by 126
Chen, A. M., Garcia, J., Lee, N. Y., Bucci, M. K., & Eisele, D. W. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.10.044 · Cited by 125
Linxweiler, M., Kuo, F., Katabi, N., Lee, M., Nadeem, Z., Dalin, M. G., Makarov, V., Chowell, D., Doğan, S., Ganly, I., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3758 · Cited by 117
Masubuchi, T., Tada, Y., Maruya, S.-I., Osamura, Y. R., Kamata, S.-E., Miura, K., Fushimi, C., Takahashi, H., Kawakita, D., Kishimoto, S., et al. (2014) · International Journal of Clinical Oncology · doi:10.1007/s10147-014-0674-6 · Cited by 116
Boon, E., van Boxtel, W., Buter, J., de Jong, R. J. B., van Es, R. J. J., Bel, M., Fiets, E., Oosting, S. F., Slingerland, M., Hoeben, A., et al. (2017) · Head & Neck · doi:10.1002/hed.25035 · Cited by 116
Mahmood, U., Bang, A., Chen, Y., Mak, R. H., Lorch, J. H., Hanna, G. J., Nishino, M., Manuszak, C., Thrash, E. M., Severgnini, M., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.08.018 · Cited by 115
Self-citationRoss, J. S., Gay, L. M., Wang, K., Vergilio, J., Suh, J. H., Ramkissoon, S. H., Somerset, H., Johnson, J. M., Russell, J. S., Ali, S. M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx399 · Cited by 114
Ultrasound‐guided core needle biopsy in salivary glands: A meta‐analysis
Kim, H. J., & Kim, J. S. (2017) · The Laryngoscope · doi:10.1002/lary.26764 · Cited by 109
Schmidt, R. L., Hall, B. J., & Layfield, L. J. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp5ltq4rvoqait · Cited by 108
Schmidt, R. L., Hunt, J. P., Hall, B. J., Wilson, A. R., & Layfield, L. J. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp2sd8rfqeuzjw · Cited by 105
Sridharan, V., Gjini, E., Liao, X., Chau, N. G., Haddad, R. I., Severgnini, M., Hammerman, P. S., El‐Naggar, A. K., Freeman, G. J., Hodi, F. S., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0031 · Cited by 101
Self-citationFarahani, S. J., & Baloch, Z. W. (2018) · Diagnostic Cytopathology · doi:10.1002/dc.24097 · Cited by 99
Wong, S. J., Karrison, T. G., Hayes, D. N., Kies, M. S., Cullen, K. J., Tanvetyanon, T., Argiris, A. E., Takebe, N., Lim, D. W., Saba, N. F., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv537 · Cited by 96
Liu, Y., Li, J., Tan, Y., Xiong, P., & Zhong, L. (2014) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2014.10.020 · Cited by 93
Howlett, D. C., Harper, B., Quante, M., Berresford, A., Morley, M., Grant, J., Ramesar, K., & Barnes, S. (2006) · The Journal of Laryngology & Otology · doi:10.1017/s0022215106004944 · Cited by 93
Skálová, A., Baněčková, M., Thompson, L. D. �., et al. (2020) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001535 · Cited by 92
Laurie, S. A., Siu, L. L., Winquist, E., Maksymiuk, A. W., Harnett, E. L., Walsh, W., Tu, D., & Parulekar, W. R. (2009) · Cancer · doi:10.1002/cncr.24745 · Cited by 90
Kiyoshima, T., Shima, K., Kobayashi, I., Matsuo, K., Okamura, K., Komatsu, S., Rasul, A. M. E., & Sakai, H. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00083-x · Cited by 86
The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland
Chen, A. M., García, J. J., Bucci, M. K., Quivey, J. M., & Eisele, D. W. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.07.1380 · Cited by 86
van Boxtel, W., Locati, L. D., Grunsven, A. C. H. V. E., Bergamini, C., Jonker, M. A., Fiets, E., Cavalieri, S., Tooten, S., Bos, E., Quattrone, P., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2018.12.035 · Cited by 83
Self-citationPhase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma
Keam, B., Kim, S., Shin, S. H., Cho, B. C., Lee, K., Kim, M. K., Yun, H., Lee, S., Yoon, D. H., & Bang, Y. (2015) · Cancer · doi:10.1002/cncr.29401 · Cited by 82
Jensen, A. D., Nikoghosyan, A. V., Lossner, K., Haberer, T., Jäkel, O., Münter, M., & Debus, J. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.05.013 · Cited by 81
Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma
Ghosal, N., Mais, K. L., Shenjere, P., Julyan, P. J., Hastings, D. L., Ward, T. H., Ryder, W. D. J., Bruce, I. A., Homer, J. J., & Slevin, N. J. (2010) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2010.09.013 · Cited by 79
Cheraghlou, S., Kuo, P., Mehra, S., Agogo, G. O., Bhatia, A. K., Husain, Z. A., Yarbrough, W. G., Burtness, B. A., & Judson, B. L. (2018) · Head & Neck · doi:10.1002/hed.24984 · Cited by 76
Adelstein, D. J., Ismaila, N., Ku, J. A., Burtness, B. A., Swiecicki, P. L., Mell, L. K., Beitler, J. J., Gross, N. D., Jones, C. U., Kaufman, M., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00441 · Cited by 76
Self-citationFine-needle aspiration cytology in the management of parotid masses: Evaluation of 249 patients
Fakhry, N., Antonini, F., Michel, J., Pénicaud, M., Mancini, J., Lagier, A., Santini, L., Turner, F., Chrestian, M.-A., Zanaret, M., et al. (2012) · European Annals of Otorhinolaryngology Head and Neck Diseases · doi:10.1016/j.anorl.2011.10.008 · Cited by 74
A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma
Goncalves, P. H., Heilbrun, L. K., Barrett, M. T., Kummar, S., Hansen, A. R., Siu, L. L., Piekarz, R., Sukari, A. W., Chao, J., Pilat, M. J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16464 · Cited by 73
Local ablative treatments of oligometastases from head and neck carcinomas
Florescu, C., & Thariat, J. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.01.004 · Cited by 72
Li, B. T., Shen, R., Offin, M. D., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.6001 · Cited by 69
Ettl, T., Stiegler, C., Zeitler, K., Agaimy, A., Zenk, J., Reichert, T. E., Gosau, M., Kühnel, T., Brockhoff, G., & Schwarz, S. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.08.006 · Cited by 66
Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma
Digonnet, A., Hamoir, M., Andry, G., Haigentz, M., Takes, R. P., Silver, C. E., Hartl, D. M., Strojan, P., Rinaldo, A., de Bree, R., et al. (2012) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-012-2172-7 · Cited by 65
Florentine, B. D., Staymates, B., Rabadi, M., Barstis, J., Black, A., & Cancer Committee of the Henry Mayo Newhall Memorial Hospital (2006) · Cancer · doi:10.1002/cncr.21976 · Cited by 64
Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling
Gargano, S., Senarathne, W., Feldman, R. A., Florento, E., Stafford, P., Swensen, J. J., Vranić, S., & Gatalica, Z. (2019) · Cancer Medicine · doi:10.1002/cam4.2602 · Cited by 62
Follow‐up of parotid pleomorphic adenomas treated by extracapsular dissection
Iro, H., Zenk, J., Koch, M., & Klintworth, N. (2012) · Head & Neck · doi:10.1002/hed.23032 · Cited by 60
ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma
Andersson, M. K., Mangiapane, G., Nevado, P. T., Tsakaneli, A., Carlsson, T., Corda, G., Nieddu, V., Abrahamian, C., Chayka, O., Rai, L., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-0194-3 · Cited by 60
Stannard, C. E., Vernimmen, F., Carrara, H., Jones, D. T. L., Fredericks, S., Hille, J. J., & de Kock, E. A. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.08.013 · Cited by 58
Cho, J., Kim, J., Lee, J. S., Chee, C. G., Kim, Y., & Choi, S. I. (2020) · Head & Neck · doi:10.1002/hed.26377 · Cited by 58
The role of elective neck dissection in patients with adenoid cystic carcinoma of the head and neck
Xiao, R., Sethi, R. K. V., Feng, A. L., Fontanarosa, J., & Deschler, D. G. (2019) · The Laryngoscope · doi:10.1002/lary.27814 · Cited by 53
Self-citationViscuse, P. V., Price, K. A. R., García, J. J., Schembri‐Wismayer, D., & Chintakuntlawar, A. V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00701 · Cited by 53
Prognostic value of programed death ligand-1 and ligand-2 co-expression in salivary gland carcinomas
Nakano, T., Takizawa, K., Uezato, A., Taguchi, K., Toh, S., & Masuda, M. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.01.015 · Cited by 52
Xu, B., Jungbluth, A. A., Frosina, D., Alzumaili, B., Aleynick, N., Slodkowska, E. A., Higgins, K. M., Ho, A. L., Morris, L. G. T., Ghossein, R. A., et al. (2019) · Histopathology · doi:10.1111/his.13944 · Cited by 52
Foo, W., Jo, V. Y., & Krane, J. F. (2016) · Cancer Cytopathology · doi:10.1002/cncy.21693 · Cited by 51
Sajed, D. P., Faquin, W. C., Carey, C. D., Severson, E. A., Afrogheh, A., Johnson, C. A., Blacklow, S. C., Chau, N. G., Lin, D. T., Krane, J. F., et al. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000945 · Cited by 49
Self-citationTanvetyanon, T., Fisher, K. J., Caudell, J. J., Otto, K. J., Padhya, T., & Trotti, A. (2015) · Head & Neck · doi:10.1002/hed.24172 · Cited by 48
Self-citationLocati, L. D., Cavalieri, S., Bergamini, C., Resteghini, C., Alfieri, S., Calareso, G., Bossi, P., Perrone, F., Tamborini, E., Quattrone, P., et al. (2019) · Head & Neck · doi:10.1002/hed.25891 · Cited by 47
Self-citationPérez‐de‐Oliveira, M. E., Wagner, V. P., Araújo, A. L. D., Martins, M. D., Santos‐Silva, A. R., Bingle, L., & Vargas, P. A. (2019) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12970 · Cited by 47
Doğan, S., Ng, C. K. Y., Xu, B., Kumar, R., Wang, L., Edelweiss, M., Scott, S. N., Zehir, A., Drilon, A. E. D. C., Morris, L. G. T., et al. (2019) · Human Pathology · doi:10.1016/j.humpath.2019.03.004 · Cited by 46
Franceschini, D., Rose, F. D., Franzese, C., Comito, T., Brina, L. D., Radicioni, G., Evangelista, A., D’Agostino, G. R., Navarria, P., & Scorsetti, M. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.12.049 · Cited by 45
Salivary Gland Cancer in the Era of Routine Next-Generation Sequencing
Todorovic, E., Dickson, B. C., & Weinreb, I. (2020) · Head and Neck Pathology · doi:10.1007/s12105-020-01140-4 · Cited by 45
Graciano, A. J., Fischer, C. A., Coelho, G. V., Steck, J. H., Paschoal, J. R., & Chone, C. T. (2018) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-018-5130-1 · Cited by 44
Xu, B., Doğan, S., Rasheed, M. R. H. A., Ghossein, R. A., & Katabi, N. (2019) · Human Pathology · doi:10.1016/j.humpath.2019.08.007 · Cited by 43
Alame, M., Cornillot, E., Cacheux, V., Tosato, G., Four, M., Oliveira, L. D., Gofflot, S., Delvenne, P., Turtoi, E., Cabello‐Aguilar, S., et al. (2020) · Theranostics · doi:10.7150/thno.42986 · Cited by 41
Fine‐needle aspiration with selective use of core needle biopsy of major salivary gland tumors
Romano, E. B., Wagner, J. M., Alleman, A. M., et al. (2017) · The Laryngoscope · doi:10.1002/lary.26643 · Cited by 36
Westergaard‐Nielsen, M., Rosenberg, T., Gerke, O., Dyrvig, A., Godballe, C., & Bjørndal, K. (2020) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13034 · Cited by 34
Saintigny, P., Mitani, Y., Pytynia, K. B., Ferrarotto, R., Roberts, D. B., Weber, R. S., Kies, M. S., Maity, S. N., Lin, S.-H., & El‐Naggar, A. K. (2018) · Cancer · doi:10.1002/cncr.31600 · Cited by 33
Arolt, C., Meyer, M. F., Rüsseler, V., Nachtsheim, L., Wuerdemann, N., Dreyer, T., Gattenlöhner, S., Wittekindt, C., Buettner, R., Quaas, A., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02551-6 · Cited by 31
Park, M. J., Oh, J. S., Roh, J., Kim, J. S., Lee, J. H., Nam, S. Y., & Kim, S. Y. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001515 · Cited by 30
Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma
Hanna, G. J., Bae, J. E., Lorch, J. H., Schoenfeld, J. D., Margalit, D. N., Tishler, R. B., Haddad, R. I., & Chau, N. G. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2020.104690 · Cited by 29
Self-citationCarboplatin and Docetaxel in Patients With Salivary Gland Carcinoma: A Retrospective Study
Okada, T., Saotome, T., Nagao, T., Masubuchi, T., Fushimi, C., Matsuki, T., Takahashi, H., Miura, K., Tsukahara, K., & Tada, Y. (2019) · In Vivo · doi:10.21873/invivo.11549 · Cited by 28
Kendi, A. T. K., Magliocca, K. R., Corey, A. S., Galt, J. R., Switchenko, J. M., Wadsworth, J. T., El‐Deiry, M. W., Schuster, D. M., Saba, N. F., & Hudgins, P. A. (2016) · American Journal of Roentgenology · doi:10.2214/ajr.15.15590 · Cited by 27
Park, Y. M., Oh, K. H., Cho, J.-G., et al. (2018) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2018.04.003 · Cited by 26
Health-related quality of life in patients with major salivary gland carcinoma
Becker, C., Pfeiffer, J., Lange, K., & Dahlem, K. (2018) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-018-4914-7 · Cited by 19
Ouyang, D., Liang, L., Ke, Z., Zheng, G., Weng, D., Yang, W., Su, Y., & Liao, G. (2017) · Head & Neck · doi:10.1002/hed.24732 · Cited by 18
Multimodal treatment of patients with minor salivary gland cancer in the case of recurrent disease
Erović, B. M., Schopper, C., Pammer, J., Vormittag, L., Maleki, A. H., Brunner, M., Heiduschka, G., Grasl, M. C., & Thurnher, D. (2010) · Head & Neck · doi:10.1002/hed.21312 · Cited by 15
Urano, M., Hirai, H., Tada, Y., Kawakita, D., Shimura, T., Tsukahara, K., Kano, S., Ozawa, H., Okami, K., Sato, Y. Z., et al. (2018) · Histopathology · doi:10.1111/his.13706 · Cited by 13
Hashimoto, K., Hayashi, R., Mukaigawa, T., Yamazaki, M., & Fujii, S. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.02.017 · Cited by 12
Schneider, T., Strehl, A., Linz, C., Brands, R. C., Hartmann, S., Beckford, F., Rosenwald, A., Kübler, A. C., & Müller-Richter, U. D. A. (2015) · Clinical Oral Investigations · doi:10.1007/s00784-015-1541-1 · Cited by 11
Lemound, J., Schenk, M., Keller, G., Stucki‐Koch, A., Witting, S., Kreipe, H. H., & Hussein, K. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12429 · Cited by 11
Almuhaimid, T. M., Lim, W. S., Roh, J., Oh, J. S., Kim, J. S., Kim, S.-J., Choi, S., Nam, S. Y., & Kim, S. Y. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2760-z · Cited by 9
Metadata
- Authors
- Geiger, J. L., Ismaila, N., Beadle, B., Caudell, J. J., Chau, N., Deschler, D., Glastonbury, C., Kaufman, M., Lamarre, E., Lau, H. Y., Licitra, L., Moore, M. G., Rodriguez, C., Roshal, A., Seethala, R., Swiecicki, P., & Ha, P.
- Venue
- Journal of Clinical Oncology
- Published
- 2021-06-10
- Volume
- 39
- Issue
- 17
- Pages
- 1909-1941
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W3157336873
- Cited by
- 441
- References
- 118
- FWCI
- 51.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.